Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Pertussis

View through CrossRef
The bacterium Bordetella pertussis causes disease by producing various virulence and adhesion factors, among them pertussis toxin (PT), filamentous hemagglutinin (FHA), pertactin (PRN) and agglutinogens (Agg), also called fimbriae (FIM) "Typical" pertussis or whooping cough starts with unspecific respiratory symptoms (catarrhal phase) followed by severe coughing spasms with whoops and vomiting (paroxysmal phase) and only after weeks or months disease severity slowly wanes (convalescent phase). "Atypical pertussis" with unspecific, long-lasting coughing episodes is seen in adolescents and adults; very young infants may die from apnoea. B. pertussis is transmitted by droplets, and neither infection nor vaccination produce long lasting protection. Macrolide antibiotics are given to patients and their contacts to reduce spread of the organism; however, antibiotics do NOT change the duration or course of the disease once symptoms are present. Whole cell pertussis vaccines (wP) consist of whole inactivated B. pertussis-cells, whereas acellular vaccines (aP) consist of one to five single components like PT, FHA, PRN or FIM. Pertussis vaccines are currently only available as combination vaccines with tetanus und diphtheria (DTP). Among these are DTwP; DTaP; TdaP; and various DTP-combinations with Hib, IPV, HBV vaccines. Whole cell pertussis (DTwP) combination vaccines are more reactogenic, whereas DTaP vaccines are generally well tolerated. Some DTwP had good efficacy/effectiveness (90%), it was low (40%) with others. Vaccine efficacy of DTaP vaccines ranges between 70% and 90%. As with most vaccines, efficiency is higher for severe disease. While pertussis vaccines did control clinical disease, protection is limited. Vaccination is recommended for all infants (three doses) worldwide with a booster in the second year of life. Many countries give additional doses at school entry and in adolescents, and some to adults. Vaccination of pregnant women effectively protects newborn infants and is increasingly recommended.
Global Health Press Pte Ltd
Title: Pertussis
Description:
The bacterium Bordetella pertussis causes disease by producing various virulence and adhesion factors, among them pertussis toxin (PT), filamentous hemagglutinin (FHA), pertactin (PRN) and agglutinogens (Agg), also called fimbriae (FIM) "Typical" pertussis or whooping cough starts with unspecific respiratory symptoms (catarrhal phase) followed by severe coughing spasms with whoops and vomiting (paroxysmal phase) and only after weeks or months disease severity slowly wanes (convalescent phase).
"Atypical pertussis" with unspecific, long-lasting coughing episodes is seen in adolescents and adults; very young infants may die from apnoea.
B.
pertussis is transmitted by droplets, and neither infection nor vaccination produce long lasting protection.
Macrolide antibiotics are given to patients and their contacts to reduce spread of the organism; however, antibiotics do NOT change the duration or course of the disease once symptoms are present.
Whole cell pertussis vaccines (wP) consist of whole inactivated B.
pertussis-cells, whereas acellular vaccines (aP) consist of one to five single components like PT, FHA, PRN or FIM.
Pertussis vaccines are currently only available as combination vaccines with tetanus und diphtheria (DTP).
Among these are DTwP; DTaP; TdaP; and various DTP-combinations with Hib, IPV, HBV vaccines.
Whole cell pertussis (DTwP) combination vaccines are more reactogenic, whereas DTaP vaccines are generally well tolerated.
Some DTwP had good efficacy/effectiveness (90%), it was low (40%) with others.
Vaccine efficacy of DTaP vaccines ranges between 70% and 90%.
As with most vaccines, efficiency is higher for severe disease.
While pertussis vaccines did control clinical disease, protection is limited.
Vaccination is recommended for all infants (three doses) worldwide with a booster in the second year of life.
Many countries give additional doses at school entry and in adolescents, and some to adults.
Vaccination of pregnant women effectively protects newborn infants and is increasingly recommended.

Related Results

Pertussis in infants, in their mothers and other contacts in Casablanca, Morocco
Pertussis in infants, in their mothers and other contacts in Casablanca, Morocco
Abstract Background In recent decades, there has been a marked increase in the number of reported cases of pertussis around the world, and pertussis continues to be a frequently oc...
Pertussis in Poland in 2022
Pertussis in Poland in 2022
IntroductionThe epidemiological situation of pertussis in Poland in 2022 was influenced by the cancellation of the COVID-19 epidemic and the introduction of an epidemic threat. Dec...
Early diagnostic value of serum sTREM-1 to Pertussis
Early diagnostic value of serum sTREM-1 to Pertussis
Objectives: The early diagnosis of pertussis is a public health issue, and there is a lack of sufficient lab testing. sTREM-1 has been found to be a potential specific marker for i...
A Machine Learning based Two-Step Cascading Method for Severe Pertussis Prediction
A Machine Learning based Two-Step Cascading Method for Severe Pertussis Prediction
Abstract Background Pertussis is a highly contagious respiratory illness that can cause severe complications, particularly in children. However, predicting which patients w...
PERTUSSIS INCIDENCE AND THE EFFECT OF REVACCINATION OF PRESCHOOL AND SCHOOL CHILDREN
PERTUSSIS INCIDENCE AND THE EFFECT OF REVACCINATION OF PRESCHOOL AND SCHOOL CHILDREN
The review is devoted to the analysis of pertussis incidence of children in the age group of 5–7, as well as strategies of DTP immunization with the help of the drugs in foreign co...
Epidemiología y estrategias de control para pertussis, una enfermedad resurgente
Epidemiología y estrategias de control para pertussis, una enfermedad resurgente
Muchos países han registrado durante los últimos 20 años un aumento alarmante en la incidencia de Bordetella pertussis, el principal agente causal de la enfermedad respiratoria agu...
Pertussis outbreak in southern Ethiopia: challenges of detection, management, and response
Pertussis outbreak in southern Ethiopia: challenges of detection, management, and response
Abstract Background Despite the availability of effective vaccines, pertussis remains endemic with high fatality rates in...
Pertussis outbreak in Southern Ethiopia: challenges of detection, management and response
Pertussis outbreak in Southern Ethiopia: challenges of detection, management and response
Abstract Background: Despite the availability of effective vaccines, pertussis remains endemic with high fatality rates in low and middle-income countries (LMIC).This study...

Back to Top